La Marató will finance with 1.5 million euros 10 IDIBELL projects in rare diseases
IDIBELL has been one of the institutions with more funded projects, up to 10, of which it leads 7, and participates in 3 more projects as a collaborator.
November 2020
New biomedical breakthroughs of Bellvitge, live streaming on November 28th
Next Saturday, November 28th, researchers of Bellvitge will present their most recent investigations to the general public. The new website Sinergia will broadcast a wide program of virtual talks. Sinergia has been specifically released to celebrate the first virtual edition of the Festival for the Research and Innovation in Health of L’Hospitalet.
The combination of two immunomodulatory drugs could be beneficial for more severe Covid-19 patients
A total of 44 researchers from the Bellvitge Biomedical Research Institute (IDIBELL) and Bellvitge University Hospital (HUB) sign an article in the International Journal of Infectious Diseases, where they demonstrate the beneficial effect of the use of corticosteroids added to tocilizumab treatment to improve the prognosis of critical patients of Covid-19.
Some drugs used to reduce stomach acid may increase false positives in the colon and rectal cancer screening
A new study analyzes the influence of proton pump inhibitor drugs on the risk of false positives in an immunological fecal occult blood test, a test used to detect colorectal cancer.
Bellvitge will study the application of artificial intelligence in the treatment of Covid-19 in ICUs
The Intensive Medicine Service of the Bellvitge University Hospital (HUB) participates, through the Bellvitge Biomedical Research Institute (IDIBELL), in the European ENVISION project, which will develop an intelligent decision support system to improve the monitoring and treatment of patients with Covid-19 in ICUs.
IDIBELL celebrates the Kickoff Meeting of the projects financed by 2019 La Marató de TV3 Foundation call
Today, the Teams platform hosted the IDIBELL Kickoff Meeting La Marató 2019, aimed at all those researchers who have obtained a research project within the “Convocatòria 2019 per a l’adjudicació d’ajudes econòmiques a projectes de recerca de càncer” by La La Marató de TV3 Foundation.
New global strategy to eliminate cervical cancer
This milestone could be achieved thanks to the increased efficacy and mass administration of the vaccine as well as the modernization of screening techniques.
Today Sinergia, a new website for the dissemination of health research and innovation in L’Hospitalet, is launched
Among the activities proposed by Sinergia are a virtual escape room through the IDIBELL laboratories, family workshops and 360º visits to Bellvitge facilities.
The impact of the pandemic on people with eating disorders and obesity
Dr. Fernando Fernández-Aranda is currently the editor-in-chief of the European Eating Disorders Review, a journal that has published a special issue in October focusing on the impact of the pandemic and lockdown on patients with eating disorders and obesity. We spoke with Dr. Fernández-Aranda about this special and the reflections they have extracted.
The European project “Oncommun-ICOnnecta’t” receives two International awards
The last month this project, developed by the Catalan Institute of Oncology and IDIBELL, with the collaboration in Portugal of the Pedro Nuñez Institute, has received the awards ” Invertir me Saúde 2020″ and “HINTT Award”.